COVID-19 / The Wellcome Trust's Jeremy Farrar Speaks Out Against Vaccine Nationalism
Jeremy Farrar, director of the Wellcome Trust, spoke to Financial Times correspondent Vanessa Kortekaas on 25 June…
Dina Spencer |
Editor
Dina Spencer is Community Manager & Digital Editor at PharmaBoardroom. She lives in Madrid and is interested in all things international.
Articles: Dina Spencer
Sanofi / USD 679 Million Investment in French Vaccine Manufacturing
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…
EMA / Ireland's Emer Cooke Set to Take The Helm
The European Medicines Agency (EMA), Europe’s regulatory body for medicines, has nominated Irish candidate Emer…
News Roundup / Italy Pharma July 2020
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
COVID-19 Vaccine / Lessons from the History of HIV
Against the backdrop of an unprecedented collaborative global push to develop a COVID-19 vaccine, pharma industry…
APAC / Singapore Pharma Exports Rise as Global API Demand Surges
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global…
News Roundup / South Africa Pharma June 2020
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
CanSinoBIO / China's Leading COVID-19 Vaccine Developer Talks Timelines
Chinese biotech CanSinoBIO is racing against the clock to have a COVID-19 vaccine ready to begin production in…
COVID-19 / BIO 2020 Panel on Radical Shifts in Global Biomedical R&D
The BIO International Convention was held digitally in June 2020, bringing together over 7,000 participants from…
News Roundup / Latin America Pharma June 2020
In recent pharma news from around Latin America, countries are beginning to manufacture their own tests and…
Top 10 / Pharma Companies in Japan
Japan’s pharma market is one of the world’s biggest, with a value of around USD 95 billion, according…
Cell & Gene Therapy / Five Companies to Know in Europe
The cell and gene therapy market was valued at USD 6 billion in 2017 and is projected to exceed USD 35 billion in…